Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2032 EUR
−3.48 M EUR
0.00 EUR
9.92 M
About BBS-BIOACTIVE BONE SUBSTITUTES
Sector
Industry
CEO
Juliusz Rakowski
Website
Headquarters
Oulu
ISIN
FI4000260583
FIGI
BBG00JXMR9G7
BBS-Bioactive Bone Substitutes Plc is a health technology company. The firm engages in the development, research, production and manufacture of bioactive bone substitute implants. Its orthobiological product, ARTEBONE, is made of long bones of reindeers that have a superior capability for bone regeneration compared to existing allograft products. The company was founded by Pekka Kalevi Aleksanteri Jalovaara in 2003 and is headquartered in Oulu, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BONEH is 0.0854 EUR — it has increased by 0.23% in the past 24 hours. Watch BBS-BIOACTIVE BONE SUBSTITUTES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BBS-BIOACTIVE BONE SUBSTITUTES stocks are traded under the ticker BONEH.
BONEH stock has risen by 3.13% compared to the previous week, the month change is a −70.48% fall, over the last year BBS-BIOACTIVE BONE SUBSTITUTES has showed a −78.72% decrease.
We've gathered analysts' opinions on BBS-BIOACTIVE BONE SUBSTITUTES future price: according to them, BONEH price has a max estimate of 0.30 EUR and a min estimate of 0.30 EUR. Watch BONEH chart and read a more detailed BBS-BIOACTIVE BONE SUBSTITUTES stock forecast: see what analysts think of BBS-BIOACTIVE BONE SUBSTITUTES and suggest that you do with its stocks.
BONEH reached its all-time high on Feb 20, 2020 with the price of 9.4048 EUR, and its all-time low was 0.0500 EUR and was reached on Nov 6, 2024. View more price dynamics on BONEH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BONEH stock is 7.49% volatile and has beta coefficient of −0.11. Track BBS-BIOACTIVE BONE SUBSTITUTES stock price on the chart and check out the list of the most volatile stocks — is BBS-BIOACTIVE BONE SUBSTITUTES there?
Today BBS-BIOACTIVE BONE SUBSTITUTES has the market capitalization of 2.27 M, it has increased by 14.81% over the last week.
Yes, you can track BBS-BIOACTIVE BONE SUBSTITUTES financials in yearly and quarterly reports right on TradingView.
BBS-BIOACTIVE BONE SUBSTITUTES is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
BONEH earnings for the last half-year are −0.07 EUR per share, whereas the estimation was −0.06 EUR, resulting in a −11.04% surprise. The estimated earnings for the next half-year are −0.07 EUR per share. See more details about BBS-BIOACTIVE BONE SUBSTITUTES earnings.
BBS-BIOACTIVE BONE SUBSTITUTES revenue for the last half-year amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next half-year.
BONEH net income for the last half-year is −1.71 M EUR, while the previous report showed −1.84 M EUR of net income which accounts for 6.95% change. Track more BBS-BIOACTIVE BONE SUBSTITUTES financial stats to get the full picture.
No, BONEH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 23.00 employees. See our rating of the largest employees — is BBS-BIOACTIVE BONE SUBSTITUTES on this list?
Like other stocks, BONEH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BBS-BIOACTIVE BONE SUBSTITUTES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BBS-BIOACTIVE BONE SUBSTITUTES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BBS-BIOACTIVE BONE SUBSTITUTES stock shows the sell signal. See more of BBS-BIOACTIVE BONE SUBSTITUTES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.